Who are Exagen's investors?

Exagen's investors include Cottonwood Technology Fund, EPIC VENTURES, H.I.G. Capital, H.I.G. HealthBridge Partners, MESA VERDE VENTURE PARTNERS, Sun Mountain Capital, Tullis Health Investors.

How much funding has Exagen raised?

Exagen has disclosed $48.8M raised across 15 rounds.

Where is Exagen headquartered?

Exagen is headquartered in Vista, US.

Exagen

NASDAQ: XGN

Vista, US · Founded 2002 · Delaware corporation · 218 employees on LinkedIn · 7 known investors

Find your way into Exagen

Paths you didn't know you had: your email and LinkedIn already hold routes to the Exagen team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Exagen develops diagnostic and monitoring tests for autoimmune diseases, including tools to distinguish connective tissue disease and assess lupus prognosis and progression. The company serves healthcare professionals and patients with chronic autoimmune conditions.

Biotech Digital Health Healthtech Medical Devices

Founders & leadership

Thierry Dervieux Chief Scientific Officer & Laboratory Director2010–2019Thierry Dervieux is a clinical diagnostics executive with over 30 years of experience in precision medicine. He is a certified laboratory director and patent holder who has contributed to the development of multiple diagnostic and monitoring assays for autoimmune and chronic diseases.

Wendy SwedickExecutive

Fortunato R. RoccaExecutive

John Aballi President & CEO | [NASDAQ: XGN]John Aballi is President and CEO of Exagen, which develops diagnostic and monitoring tests for autoimmune diseases including connective tissue disease and lupus. He brings 19 years of experience in diagnostic operations across early-stage, mid-market, and mature companies.

Jeffrey Black Chief Financial OfficerJeffrey Black is Chief Financial Officer and Corporate Secretary at Exagen, a diagnostics company focused on autoimmune disease testing. He brings over 30 years of finance and operations experience across medical device, diagnostics, life sciences, and biotech sectors, including senior financial roles at multiple publicly-traded companies and involvement in transactions exceeding $1 billion.

Board

James L.L. Tullis Board directorFounding Partner at Tullis Health Investors

Brian BirkBoard directorManaging Partner at Sun Mountain Capital

Ebetuel PallaresBoard director

Curt LaBelleBoard directorGeneral Partner at Tullis

Beto PallaresBoard director

Arthur WeinsteinBoard director

John M. RadakBoard director

Investors · 7

Cottonwood Technology Fundlisted by Cottonwood Technology FundDenver · $1M – $25M

How we know: Cottonwood Technology Fund's portfolio page · the VCSheet dataset · Not right? Tell us

EPIC VENTURESlisted by EPIC VENTURESSalt Lake City

How we know: EPIC VENTURES's portfolio page · Not right? Tell us

H.I.G. Capitallisted by H.I.G. CapitalMiami

H.I.G. HealthBridge Partnerslisted by H.I.G. HealthBridge PartnersMiami · $5M – $40M

How we know: H.I.G. HealthBridge Partners's portfolio page · Not right? Tell us

MESA VERDE VENTURE PARTNERSlisted by MESA VERDE VENTURE PARTNERSLa Jolla

How we know: MESA VERDE VENTURE PARTNERS's portfolio page · Not right? Tell us

Sun Mountain Capitallisted by Sun Mountain CapitalSanta Fevia Brian Birk · board

How we know: board seat on SEC Form D · Not right? Tell us

Tullis Health Investorslisted by Tullis Health InvestorsPalm Beach Gardens · $500K – $10M

How we know: Tullis Health Investors's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$48.8M disclosed across 15 rounds · 2014–2019

▶$6.6MraisedFeb 2019 · 4 investors · Biotechnology

Rule 506(b)